Abstract
When a literary author is gifted in the dual aspects of his work, observing and recording, his descriptions are often more vivid and may be more accurate than more “scientific” depictions. From what follows the next morning in Chapter VII of Huckleberry Finn, when his father awakens smiling, friendly, quite well, and with no recollection whatever of the preceding night, we may reasonably infer that Huck’s father’s case of “horrors” or what might now be termed a “bad trip” was acute alcoholic delirium with a blackout, not delirium tremens. That is supported by the fact that the episode occurred while he was drinking, not during withdrawal from alcohol.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aghajanian, G. K., and Haigler, H. J., 1975, Hallucinogenic indoleamines: Preferential
action upon presynaptic serotonin receptors, Psychopharmacol. Commun. 1: 619.
Agnew, N., and Hoffer, A., 1955, Nicotinic acid modified lysergic acid diethylamide psychosis, J. Ment. Sci. 101: 12.
Altura, B. T., and Altura, B. M., 1981, Phencyclidine, lysergic acid diethylamide, and mescaline: Cerebral artery spasms and hallucinogenic activity, Science 212: 1051.
Anden, N.-E., Corrodi, H., Fuxe, K., and Hiikfelt, T., 1968, Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide, Br. J. Pharmacol. 34: 1.
Anden, N.-E., Corrodi, H., and Fuxe, K., 1971, Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons, J. Pharmacol. Exp. Ther. 179: 236.
Angrist, B., Rotrosen, J., and Gershon, S., 1974, Assessment of tolerance to the hallucinogenic effects of DOM, Psychopharmacologia 36: 203.
Appel, J. B., and Freedman, D. X., 1964, Chemically-induced alterations in the behavioral effects of LSD-25, Biochem. Pharmacol. 13: 861.
Apter, J. T., 1958, Analeptic action of lysergic acid diethylamide (LSD-25) against pentobarbital,
A.M.A. Arch. Neurol. Psychiat. 79: 711.
Axelrod, J., Brady, R. O., Witkop, B., and Evarts, E. V., 1957, The distribution and metabolism of lysergic acid diethylamide, Ann. N.Y. Acad. Sci. 66: 435.
Baker, R. W., Chothia, c., Pauling, P., and Weber, H. P., 1972, Molecular structure of LSD, Science 178: 614.
Balster, R. L., Johanson, C. E., Harris, R. T., and Schuster, C. R., 1973, Phencyclidine selfadministration in the rhesus monkey, Pharmacol. Biochem. Behav. 1: 167.
Bergen, J. R., Krus, D. M., and Pincus, G. G., 1960, Suppression of LSD-25 effects in rats by steroids, Proc. Soc. Exp. Bioi. Med. 105: 254.
Beringer, K., 1927, Der Meskalinrausch, Springer Verlag, Berlin.
BieJ, J. M., 1970, Structure-activity relationships of amphetamine and derivatives, in: Amphetamines and Related Compounds ( E. Costa and S. Garratini, eds.) pp. 3–19, Raven Press, New York.
Brengdmann, J. C., Pare, C. M. B., and Sandler, M., 1958, Alleviation of the psychological effects of LSD in men by 5-hydroxytryptophan, J. Ment. Sci. 104: 1237.
Bums, R. S., and Lerner, S. E., 1976, Perspectives: Acute phencyclidine intoxication, Clin. Toxicol. 9: 477.
Burton, R. M., 1957, The analeptic action of lysergic acid diethylamide on reserpine-treated mice, Ann. N.Y. Acad. Sci. 66: 695.
Caporael, L. R., 1976, Ergotism: The Satan loosed in Salem? Science 192: 21.
Carter, R. B., and Appel, J. B.o 1978, LSD and 5-HTP: Tolerance and cross-tolerance relationships, Eur. J. Pharmacol. 50: 145.
Cogen, F. C., Rigg, G., Simmons, J. L., and Domino, E. F., 1978, Phencyclidine-associated acute rhabdomyolysis, Ann. Intern. Med. 88: 210.
Cooper, P. D., and Walters, G. c., 1972, Sterochemical requirements of the mescaline receptor, Nature 238: 96.
Corrodi, H., Fuxe, K., Hiikfelt, T., Lidbrink, P., and Ungerstedt, U., 1973, Effect of ergot drugs on central catecholamine neurons: Evidence for stimulation of central dopamine neurons, J. Pharm. Pharmacol. 25: 409.
DaPrada, M., Saner, A., Burkard, W. P., Bartholini, G., and Pletscher, A., 1975, Lysergic acid diethylamide: Evidence for stimulation of cerebral dopamine receptors, Brain Res. 94: 67.
deMello, A. c., Carlini, E. A., Dressler, K., Green, J. P., Kang, S., and Margolis, S., 1973,
Behavioral observations on compounds found in nutmeg, Psycho pharmacologia 31:349.
deQuincey, T., 1822, Confessions of an English Opium-Eater, Taylor and Hessey, London.
Diab, I. M., Freedman, D. X., and Roth, L. J., 1971, [3Hl Lysergic acid diethylamide: Cellular autoradiographic localization in rat brain, Science, 173: 1022.
Diaz, J-L., and Huttiinen, M. 0., 1971, Persistent increase in brain serotonin turnover after chronic administration of LSD in the rat, Science, 174: 62.
Ditman, K. S., 1963, Psychotomimetics: Pharmacodynamic and psychotherapeutic properties, Proc. West. Pharmacol. Soc. 6: 13
Domino, E. F., 1978, Neurobiology of Phencyclidine-an update, in: Phencyclidine (PCP) Abuse: An Appraisal (R. C. Peterson and R. C. Stillman, eds.) Ch. 2., National Institute of Drug Abuse, Washington.
Efron, D. H., Holmstedt, B., and Kline, N. S., 1967, Ethnopharmacologic search for psychoactive drugs, Public Health Service Publication no. 1645.
Elder, J. T., and Dille, J. M., 1962, An experimental study of the participation of the sympathetic nervous system in the lysergic acid diethylamide ( LSD) reaction in cats, J. PharTrulcol. Exp. Ther. 136: 162.
Ellinwood, E. H., and Petrie, W. M., 1976, Psychiatric syndromes induced by nonmedical use of drugs, in: Research Advances in Alcohol and Drug Problems Vol. 3 ( R. J. Gibbins, Y. Israel, H. Kalant, R. E. Popham, W. Schmidt, and R. G. Smart, eds.), pp. 182–188, Wiley, New York.
Fabing, H. D., 1955, New blocking agent against the development of LSD-25 psychosis, Science 121: 208.
Fessler, R. G., Sturgeon, R. D., and Meltzer, H. Y., 1979, Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra, Life Sci. 24: 1281.
Gaddum, J. H., 1953, Antagonism between lysergic acid diethylamide and 5 hydroxytryptamine, J. Physiol. 121: 15 P.
Garey, R. E., and Heath, R. G., 1976, The effects of phencyclidine on the uptake of 3H catecholamines by rat striatal and hypothalamic synaptosomes, Life Sci. 18: 1105.
Gerard, R. W., 1956, Discussion report in: NeuropharTrUlcology: Transactions of the Second Conference (Abramson, H. A., ed.), pp 240 - 241, Josiah Macy, Jr., Foundation, New York.
Giberti, F., and Gregoretti, L., 1955, Prime esperienzi di antagonismo psicofarmacologico. Psicosi sperimentali da LSD e trattamento con cloropromazina e reserpina, Sisto Nerv. 7: 301.
Ginzel, K. H., and Mayer-Gross, W., 1956, Prevention of psychological effects of d- lysergic acid diethylamide (LSD-25) by its 2-brom derivative (BOL-148), Nature 178: 210.
Headley, E. D., and Synder, S. H., 1971, Correlation between psychotropic potency ofpsychotomimetic methoxyamphetamines and their inhibition of 3H-normetanephrine uptake in rat cerebral cortex. Nature 229: 264.
Hitner, H., and DiGregorio, G. J., 1974, Preliminary investigation ofthe peripheral sympathomimetic effects of phencyclidine, Arch. Int. PharTrUlcodyn. Ther. 212: 36.
Hitzemann, R. J., Loh, H. H., and Domino, E. F., 1973, Effect of phencyclidine on the accumulation of 14C-catecholamines formed from 14C-tyrosine, Arch. Int. PharTrUlcodyn. Ther. 202: 252.
Hoffer, A., and Osmond, H., 1967, The Hallucinogens. Academic Press, New York.
Hofmann, A., and Tscherter, H., 1960, Isolierung von Lysergsiiure-alkaloiden aus der mexicanischen Zauberdroge Ololiuqui ( Rivea Corymbosa [L.] Hall.f. ), Experientia 16: 414.
Hollister, L. E., and Moore, F., 1967, Urinary catecholamine excretion following lysergic acid diethylamide in man, PsychopharTrUlcologia 11: 270.
Horita, A., 1963, Some biochemical studies on psilocybin and psilocin, J. Neuropsychiatry 4: 270.
Horita, A., and Dille, J. M., 1954, Pyretogenic effect of lysergic acid diethylamide, Science 120: 1100.
Hyvarinen, J., Laasko, M., Roine, R., and Leinonen, L., 1979, Effects of phencyclidine, LSD, and amphetamine on neuronal activity in the posterior parietal association cortex of the monkey, NeuropharTrUlcology 18: 237.
Isbell, H, and Gorodetzky, C. W., 1966, Effects of alkaloids of ololiuqui in man, Psychopharmacologia 8: 331.
Isbell, H., Logan, C. R., and Miner, E. J., 1959a, Studies on lysergic acid diethylamide (LSD- 25). III. Attempts to attenuate the LSD reaction in man by pretreatment with neurohumoral blocking agents, A.M.A. Arch. Neurol. Psychiat. 81: 20.
Isbell, H., Miner, E. J., and Logan, C. R., 1959b, Cross tolerance between D-2-bromlysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25), PsychopharTrUlcologia 1: 109.
James, S. H., and Schnoll, S. H., 1976, Phencyclidine: Tissue distribution in the rat, Clin. Toxicol. 9: 573.
Ian, K.-M., Dorsey, S., and Bornstein, A., 1978, Hot hog: Hyperthennia from phencyclidine, N. Engl. l. Med. 299: 722.
Iohnston, V. S., and Bradley, R. J., 1968, Molecular pharmacology of hallucinogens, Recent Adv. Bioi. Psychiat. 10: 74.
Kanner, M., Finnegan, K., and Meltzer, H. Y., 1975, Dopaninergic effects of phencyclidine in rats with nigrostriatallesions, Psychopharmacol. Commun. 1: 393.
Kluver, H., 1926, Mescal visions and eidetic vision, Am. l. Psychol. 37: 502.
Knoll, I., and Vizi, E. S., 1970, Inhibition of the effects of LSD and p bromomethamphetamine ( V-III) by p-chlorophenylalanine, Pharmacol. Res. Comm. 2: 67.
Koella, W. P., Beaulieu, R. F., and Bergen, I. R., 1964, Stereotyped behavior and cyclic changes in response produced by LSD in goats, Int. l. Neuropharmacol. 3: 397.
Krus, S., Wapner, S., Bergen, I., and Freeman, H., 1961, The influence of progesterone on behavioral changes induced by lysergic acid diethylamide (LSD-25) in normal males, Psychopharmacologia 2: 177.
Lerner, S. E., and Burns, S., 1978, Phencyclidine use among youth: History, epidemiology, and acute and chronic intoxication, in: Phencyclidine (PCP) Abuse: An Appraisal (R. C. Petersen and R. C. Stillman, eds.) Ch. 5, National Institute of Drug Abuse, Washington.
Lewin, L., 1964, Phantastica: Narcotic and Stimulating Drugs, E. F. Dutton, New York.
Liden, C. B., Lovejoy, F. H., and Costello, C. E., 1975, Phencyclidine; nine cases of poisoning, l.A.M.A. 234: 513.
Luisada, P. V., and Brown, B. I., 1976, Clinical management of the phencyclidine psychosis, Clin. Toxicol. 9: 539.
Maayani, S., Weinstein, H., Ben-Zui, N., Cohen, S., and Sokolovsky, M., 1974, Psychotomimetic agents as anticholinergic agents. J, Biochem. Pharmacol. 23: 1263.
Martin, D. P., Darrow, C. c., Valerio, D. A., and Leiseca, S. A., 1972, Methods of anesthesia in nonhuman primates, Lab. Anim. Sci. 2: 837.
Martin, I. R., Berman, M. H., Krewsun, I., and Small, S. F., 1979, Phencyclidine-induced stereotyped behavior and serotoninergic syndrome in rat, Life Sci. 24: 1699.
Menon, M. K., Tseng, L.-F., and Loh, H. H., 1976, Pharmacological evidence for the central serotoninergic effects of monomethyoxyamphetamines, l. Pharmacol. Exp. Ther. 197: 272.
Messiha, F. S., and Grof, S., 1973, D-lysergic acid diethylamide (LSD)-effect on biogenic amines excretion in man, Biochem. Pharmacol. 22: 2352.
Misra, A. L., Pontani, R. B., and Bartolomeo, I., 1979, Persistence of phencyclidine (PCP) and metabolites in brain and adipose tissue and implications for long-lasting behavioral effects, Res. Commun. Chem. Pathol. Pharmacol. 24: 431.
Moreau, 1.-1., 1973, Hashish and Mental Illness, Raven Press, New York.
Murphree, H. B., 1962, Quantitative studies in humans on the antagonism of lysergic acid diethylamide by chlorpromazine and phenoxybenzamine, Clin. Pharmacol. Ther. 3: 314.
Murphree, H. B., DeMaar, E. W. I., Williams, H. L., and Bryan, L. L., 1958, Effects of lysergic acid derivatives on man: Antagonism between d-lysergic acid diethylamide and its 2-brom congener. J. Pharmacol. Exp. Ther. 122: 55a.
Murphree, H. B., Ienney, E. H., and Pfeiffer, C. C., 1960, Comparison of the effects of congeners of lysergic acid diethylamide and tryptophane in normal human volunteers, Pharmacologist 2: 64.
Murphree, H. B., Dippy, W. H., Ienney, E. H., and Pfeiffer, C. C., 1961, Effects in normal man of a-methyltryptamine and a-ethyltryptamine, Clin. Pharmacol. Ther. 6: 722.
Murphree, H. B., Ienney, E. H., and Pfeiffer, C. C., 1962, Quantitative electroencephalographic analysis of the effects of lysergic acid diethylamide (LSD-25) and d-amphetamine in man, Fed. Proc. 21: 337.
Murray, T. F., and Horita, A., 1979, Phencyclidine-induced stereotyped behavior in rats: Doseresponse effects and antagonism by neuroleptics, Life Sci. 24: 2217.
Nathan, P. E., Titler, N. A., Lowenstein, L. M., Solomon, P., and Rossi, A. M., 1970, Behavioral analysis of chronic alcoholism, Arch. Gen. Psychiat. 22: 419.
Osmond, H., 1957, A review of the clinical effects of psychotomimetic agents, Ann. N.Y. Acad. Sci. 66: 418.
Pare, C. M. B., and la Brosse, E. H., 1963, A further study on alleviation of the psychological effects of LSD in man by pretreatment with 5-hydroxytryptophan, J. Psychiatr. Res. 1: 271.
Paster, Z., Maayani, S., Weinstein, H., and Sokolovsky, M., 1974, Cholinolytic action of phencyclidine derivatives, Eur. J. Pharmacol. 25: 270.
Pearson, K. C., 1981, Mental disorders from low-dose bromocriptine, N. Engl. J. Med. 305: 173.
Pfeiffer, C. C., 1956, Optical isomerism and pharmacological action, a generalization. Science 124: 29.
Pieri, L., Pieri, M., and Haefely, W., 1974, LSD as an agonist of dopamine receptors in the striatum, Nature 252: 586.
Pieri, L., Keller, H. H., Burkard, W., and daPrada, M., 1978, Effects of lisuride and LSD on monoamine systems and hallucinosis, Nature 272: 278.
Resnick, 0., Krus, D. M., and Raskin, M., 1965, Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine, Life Sci. 4: 1433.
Schlemmer, R. F., Jackson, J. A., Preston, K. L., Bederka, J. P., Garver, D. L. and Davis, J. M., 1978, Phencyclidine-induced stereotyped behavior in monkeys: Antagonism by pimozide, Eur. J. Pharmacol. 52: 379.
Schultes, R. E., and Hofmann, A., 1973, The Botany and Chemistry of Hallucinogens, Charles C. Thomas, Springfield, Illinois.
Schwarz, B. E, Bickford, R. G., and Rome, H. P., 1955, Reversibility of induced psychosis with chlorpromazine, Proc. Staff Meetings Mayo Clin. 30: 407.
Shulgin, A. T., 1973a, Mescaline: The chemistry and pharmacology of its analogs, Lloydia 36: 46.
Shulgin, A. T., 1973b, Stereospecific requirements for hallucinogenics, J. Pharm. Pharmacol. 25: 271.
Shulgin, A. T., Sargent, T., and Naranjo, E., 1969, Structure-activity relationships of one-ring psychotomimetics, Nature 221: 537.
Siegel, R. K., 1978, Phencyclidine and ketamine intoxication: A study of four populations of recreational users, in: Phencyclidine ( PCP) Abuse: An Appraisal (R. C. Petersen and R. C.
Stillman, eds.), Ch. 6., National Institute of Drug Abuse, Washington.
Slaytor, M. B., and Wright, S. E., 1962, The metabolites of ergometrine and lysergic acid diethylamide in rat bile, J. Med. Pharm. Chem. 5: 483.
Slotta, K. H., and Miiller, J., 1936, Uber den Abbau des Mescalins und mescaliniihnlicher Stoffe im Organismus Ztschr. f. Physiol. Chem. 238: 14.
Smith, D. E., 1981, West coast and east coast drug abuse patterns, 1979-1980, Ann. N.Y. Acad. Sci. 362: 22.
Smith, R. C., Meltzer, H. Y., Arora, R. C., and Davis, J. M., 1977, Effects of phencyclidine on [pH] catecholamine and [3H] serotonin uptake in synaptosomal preparations from rat brain, Biochem. Pharmacol. 26: 1435.
Snyder, S. H., Unger, S., Blatchley, R., and Barfknecht, C. F., 1974, Stereospecific actions of DOET (2,5-dimethyoxy-4-ethylamphetamine) in man, Arch. Gen. Psychiat. 31: 103.
Sokoloff, L., Perlin, c., Kornetsky, C, and Kety, S. S., 1957, The effects of d-lysergic acid
diethylamide on cerebral circulation and overall metabolism, Ann. N.Y. Acad. Sci. 66: 468.
Stecher, P. G., ed., 1968, The Merck Index: An Encyclopedia of Chemicals and Drugs, 8th Ed. Rahway, N.J.
Stockard, J. J., Werner, S. S., Aalbers, J. A., and Chiappa, K. H., 1976, Electroencephalographic findings in phencyclidine intoxication, Arch. Neurol. 33: 200.
Stoll, A., and Hofmann, A., 1943, Partial Synthese von Alkaloiden vom Typus des Ergobasins, Helv. Chim. Acta 26: 944.
Stoll, W.A., 1947, Lysergsiiurediiithylamid, ein Phantastikum aus der Mutterkorngruppe, Schweiz. Arch. Neurol. Psychiat. 60: 279.
Szara, S., 1961, Hallucinogenic effects and metabolism of tryptamine derivatives in man, Fed. Proc. 20: 885.
Szara, S., 1963, Enzymatic formation of a phenolic metabolite from lysergic acid diethylamide by rat microsomes, Life Sci. 9: 662.
Troxler, F., and Hofmann, A., 1959, Oxydation von Lysergsaure-Derivaten in 2,3-Stellung, Helv. Chim. Acta 42: 793.
Vinar, 0., 1958, Analogien zwischen schizophrenen Erkrankungen und der LSD-Psychose, Psy_ chiatr. Neurol. Med. Psychol. 10: 162.
von Hungen, K., Roberts, S., and Hill, D. F., 1974, LSD as an agonist and antagonist at central dopamine receptors, Nature 252: 588.
Weinstein, H., Maayani, S., Srebrinik, S., Cohen, S., and Sokolovsky, M., 1973, Psychotomimetic drugs as anticholinergic agents. II, Mol. Pharmacol. 9: 820.
Wikler, A., Rosenberg, D. E., Hawthorne, 1. D., and Cassidy, T. M., 1965, Age and effect of LSD-25 on pupil size and knee jerk threshold, Psychopharmacologia 7: 44.
Winter, 1. C., 1973, A comparison of the stimulus properties of mescaline and 2,3,4-trimethoxyphenylethylamine, J. Pharmacol. Exp. Ther. 185: 101.
Wong, L. K., and Biemann, K., 1975, Metabolites of phencyclidine in humans, Biomed. Mass Spectrom. 2: 204.
Wong, L. K., and Biemann, K., 1976, Metabolites of phencyclidine, Clin. Toxicol. 9: 583.
Wooley, D. W., and Shaw, E. N., 1957, Evidence for the participation of serotonin in mental processes, Ann. N.Y. Acad. Sci. 66: 649.
Wright, E. M., 1972, Active transport of lysergic acid diethylamide, Nature 240: 53.
Ziegler, M. G., Lovell, R. A., and Freedman, D. X., 1973, Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro, Biochem. Pharmacol. 22: 2183.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Murphree, H. (1983). The Pharmacology of Hallucinogens. In: Research Advances in Alcohol and Drug Problems. Research Advances in Alcohol and Drug Problems, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3626-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3626-6_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3628-0
Online ISBN: 978-1-4613-3626-6
eBook Packages: Springer Book Archive